Cancer has become a significant global health concern. In 2022, the projected number of new cancer cases worldwide was 20 million. This number is expected to rise by 77% by 2050. With the growing number of cancer cases, it is now more important than ever to invest in new cancer research.
Science is making new strides every day, making cancer treatment and care for patients easier and bearable, increasing the survival rates of cancer.
In a huge milestone, breaking the boundaries of Ayurveda—Body Revival, Health Reactive has become the first Ayurvedic product to conduct human clinical trials. This clinical trial is the first step towards uniting ancient Ayurvedic wisdom with modern science. This research is also important, as it clinically demonstrates the potential of Body Revival and Ayurveda in cancer care for breast cancer patients.
Importance of Cancer Research
The clinical trial by Health Reactive highlights a new way for cancer care. The trial was conducted at J.B. Roy State Ayurvedic Medical College & Hospital – Dept. of Health & Family Welfare (AYUSH), Govt. of W.B., The West Bengal University of Health Sciences (Affiliated). The West Bengal University of Health Sciences (Affiliated). The trial started on 1st October 2023 and lasted 11 months, ending on 30th November 2024. In the trial on breast cancer patients, it highlighted that:
- Improved Quality of Life: Patients who used Body Revival noticed an increase in stamina and overall quality of life.
- Reduce Side Effects: Body Revival helped reduce the side effects of chemotherapy and radiotherapy, including nausea, vomiting, weight loss, and hair loss. This made cancer treatment a little easier for patients.
- Safe and Reliable for use: Body Revival has been proven to be a safe and well-tolerated option, even for patients undergoing intense treatments. This finding reassures its safety and suitability for a wide range of patients.
- Recommended by Experts: The medical team involved in the trial recommended Body Revival as a safe and effective option for cancer patients.
In addition, patients saw increased levels of haemoglobin and blood platelets, highlighting that Body Revival also has immunotherapy properties. It is a safe alternative that can complement conventional cancer treatments.
Body Revival Clinical Trial in Media
The clinical trial is big news as it is the first in the world to prove that Ayurveda can help in breast cancer care scientifically. It was covered by major media houses like Dainik Bhaskar, Press Trust of India, Hindustan Express.
It was also presented at the 10th World Ayurveda Congress held from 12th December 2024 to 15th December 2024 in Dehradun, Uttarakhand, India. The presentation was well-received, with many experts expressing interest in the potential of Ayurveda in cancer care. The Clinical trial was conducted on breast cancer patients who had undergone chemotherapy and radiotherapy for their cancer treatment.
Body Revival was designed using carefully selected Ayurvedic herbs, which aim at helping the body recover strength and deal with the challenges of cancer treatment. This clinical trial has shown that it offers hope and support to cancer patients when they need it most.
What makes Body Revival unique?
Body Revival isn’t just another ayurvedic product. It’s the result of years of research and development, rooted in the time-tested principles of Ayurveda. We have been helping cancer patients since 1996.
Body Revival is made from six ingredients, namely – Bael, Kukrondha, Muskmelon Seeds, Garlic, Haritaki and Honey.
What’s Next?
While we’re thrilled with this success, we’re already looking ahead. Our goal is to make Body Revival and other Ayurvedic solutions available to more people so that they can experience the benefits of natural healing.
We also want to inspire more collaboration between Ayurveda and modern medicine.
Together, they have the power to create a future where healthcare is not just about treating illness but also about improving overall well-being.